CMS Proposes to Modernize CLIA in Broad Rule
What clinical labs need to know about virtual access, director qualifications, and more
What clinical labs need to know about virtual access, director qualifications, and more
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027
CMS tweaked its CE, documentation, and on-site visit requirements for directors
Third-party verification of lab personnel experience is now a CLIA requirement
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Clinical labs gain flexibility in meeting regulatory standards while potentially reducing their costs
Washington State’s Department of Health details how its medical testing site program meets federal standards